Fore Capital, LLC Gilead Sciences, Inc. Transaction History

Fore Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $676,900 - $730,300	-10,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $634,700 - $693,500	10,000 New	10,000 $689,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $300,000 - $342,299	-5,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $283,250 - $322,750	5,000 New	5,000 $291,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Fore Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fore Capital, LLC with notifications on news.